IP Library Granted Patent US 10,954,556
Granted Patent B2
US 10,954,556 · App. 16/134,254 · Granted Mar 23, 2021

Normalization of polymerase activity

Inventors: Hatim Allawi (Middleton, WI); Rebecca Oldham-Haltom (Marshall, WI); Zubin Gagrat (Madison, WI); Michael Domanico (Middleton, WI); Graham Lidgard (Madison, WI)
C12Q1/686C12Q1/6851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,954,556
App. No.
16/134,254
Granted
Mar 23, 2021
Kind
B2
Abstract

Provided herein is technology relating to the amplification-based detection of nucleic acids and particularly, but not exclusively, to methods and compositions for minimizing variability in the activity between different samples or manufacturing lots of DNA polymerases, such as Taq DNA polymerase.

Claims (24)

1. A method for quantitating target nucleic acid, comprising:

a) providing a reaction mixture comprising:

i) an amount of target nucleic acid;

ii) purified exogenous non-target DNA isolated from fish at a concentration of approximately 2 to 20 nanograms per μl of reaction mixture; and

iii) PCR amplification assay reagents comprising:

thermostable DNA polymerase;

dNTPs;

a first primer and a second primer configured for amplifying a DNA product from the target nucleic acid;

a flap endonuclease; and

an oligonucleotide probe;

wherein the reaction mixture is characterized in that it can amplify the DNA product from the target nucleic acid and produce an amount of amplified DNA product proportional to the amount of the target nucleic acid in the reaction mixture;

b) conducting an amplification reaction with the reaction mixture and measuring DNA product amplified from the target nucleic acid during the amplification reaction; and

c) calculating the amount of the target nucleic acid in the reaction mixture.

2. The method of claim 1 , where the purified exogenous non-target DNA isolated from fish comprises DNA isolated from herring and/or cod and/or salmon.

3. The method of claim 1 , wherein the purified exogenous non-target DNA isolated from fish is added at a concentration of approximately 6 to 7 nanograms per μl of reaction mixture.

4. The method of claim 1 , wherein the oligonucleotide probe is a flap oligonucleotide.

5. The method of claim 1 , wherein the reaction mixture comprises an oligonucleotide with a fluorescent label.

6. The method of claim 1 , wherein the thermostable DNA polymerase is a thermostable eubacterial DNA polymerase.

7. The method of claim 6 , wherein the eubacterial DNA polymerase is from Thermus aquaticus.

8. The method of claim 1 , wherein the DNA polymerase is modified for hot start PCR.

9. The method of claim 1 , wherein the flap endonuclease is a FEN-1 endonuclease.

10. The method of claim 9 , wherein the FEN-1 endonuclease is from an archaeal organism.

11. The method of claim 1 , wherein the target nucleic acid is human nucleic acid.

12. The method of claim 11 , wherein the human nucleic acid comprises human genomic DNA.

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058738/0465 →
Cited By (1)
US 12,385,087